A novel supplemental approach to capturing post-marketing safety information on recombinant factor VIIa in acquired hemophilia: the Acquired Hemophilia Surveillance project

Overview of attention for article published in Journal of Blood Medicine, January 2014

Altmetric Badge

Mentioned by

twitter: 1 X user

Citations

dimensions_citation: 6 Dimensions

Readers on

mendeley: 9 Mendeley

Summary X Dimensions citations

So far, Dimensions has found 6 publications that cite this research output.

6

The most recent citing publications are shown below. View all 6 publications that cite this research output on Dimensions.

Current status and future prospects of activated recombinant coagulation factor VIIa, NovoSeven®, in the treatment of haemophilia and rare bleeding disorders

Article in Annals of Hematology (June 2023)

Lessons from a systematic literature review of the effectiveness of recombinant factor VIIa in acquired haemophilia

Article in Annals of Hematology (May 2018)

Assessment of acquired hemophilia patient demographics in the United States

Article in Blood Coagulation & Fibrinolysis (July 2016)